Lonza | LONN - Ebitda



Lonza reported CHF1.01B in EBITDA for its fiscal semester ending in December of 2024.


Ebitda Change Date
Akzo Nobel EUR 393M 35M Jun/2025
Alcon AG USD 250M 213M Jun/2025
Almirall EUR 76.3M 8.43M Mar/2025
AstraZeneca USD 4.96B 127M Jun/2025
BASF EUR 1.77B 1.2B Jun/2025
Bayer EUR 236M 3.35B Jun/2025
Beiersdorf EUR 837M 163M Dec/2024
Covestro EUR 266M 129M Jun/2025
Demant DKK 2.59B 473M Jun/2025
Fresenius EUR 828M 88M Jun/2025
Fresenius Medical Care EUR 871M 282M Jun/2025
Geberit CHF 276.9M 40.8M Mar/2025
Genmab DKK 376M 172M Jun/2025
Givaudan CHF 910M 196M Jun/2024
GlaxoSmithKline GBP 3.18B 45M Jun/2025
GN Store Nord DKK 639M 42M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Johnson Matthey GBP 371M 121M Mar/2025
Merck EUR 1.46B 45M Jun/2025
Novartis USD 6.17B 339M Jun/2025
Philips EUR 747M 174M Jun/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 1.89B 971M Jun/2025
Sika AG CHF 1.1B 48.9M Jun/2024
Smith & Nephew USD 796M 48.8M Jun/2025
Solvay EUR 230M 4M Jun/2025
UCB EUR 1.37B 715M Dec/2024